Developing better treatments in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Developing better treatments in hepatocellular carcinoma.

Developing better treatments in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37798817

about

Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma.CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.Design, Synthesis and Evaluation of Naphthalimide Derivatives as Potential Anticancer Agents for Hepatocellular Carcinoma.4,5-Diaryl imidazoles with hydroxamic acid appendages as anti-hepatoma agents.Chaperonin containing TCP1, subunit 8 (CCT8) is upregulated in hepatocellular carcinoma and promotes HCC proliferation.BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.

P2860

Q34401887-F38E2E6B-AA32-49DC-86A5-3B506DF4792E Q36223538-49678528-C433-4F85-9FC1-E1B9A0AC5D3A Q36729432-DD7DEA7D-EAA7-46DD-AB0E-D4D8A3A2B571 Q37496310-B7EF4E74-F30B-4693-AC79-FCF3394F9318 Q38319523-802FF968-6D5C-4959-AB31-B9A9E8AADB7C Q38714663-1A76A7A5-107C-407A-8C8C-4410027BFEAF Q38939131-AB96FFCC-1C12-403D-A417-CFA6DC4A780A Q38991495-9E7A10F1-68DE-4CA6-9D88-1B02DDBAD0B7 Q39202649-AA6A0CA3-CB10-4D35-A421-98ECEFE57EA5 Q39384326-D7D65470-2456-4623-83F8-D3A4702A7F07 Q39562032-F1D031D4-E47C-460A-874F-BBB76043536B

P2860

Developing better treatments in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37798817

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Developing better treatments in hepatocellular carcinoma.

@en

Developing better treatments in hepatocellular carcinoma.

@nl

type

label

Developing better treatments in hepatocellular carcinoma.

@en

Developing better treatments in hepatocellular carcinoma.

@nl

prefLabel

Developing better treatments in hepatocellular carcinoma.

@en

Developing better treatments in hepatocellular carcinoma.

@nl

P1433

Q37798817-4A591306-72B4-4A0C-813C-99EB60A97B9E

P1476

Q37798817-CE948F3D-0F34-4A8A-AC9A-7680F0E4E5D5

P2093

Q37798817-22D62759-C577-4BD7-B641-666B4B90ACD0

Q37798817-DB928980-1AAE-481E-B3F0-DCFA2D8258F4

P2860

Q37798817-006CA25A-D755-47F2-AED6-2D252326199A

Q37798817-014601AD-8F35-41EC-92F3-E5B4DEE15830

Q37798817-072CFCAA-0EBC-4B9F-B0FC-21A7191076EE

Q37798817-093B942D-4559-41F8-92B6-93B272446076

Q37798817-0FEA8D29-381D-4D63-A855-C446D39CCC0B

Q37798817-149C07A0-23AC-4BF3-82A8-D62FCB059C05

Q37798817-16302EE0-3DE6-41A4-9536-2986F848D7C6

Q37798817-1AFDF893-8E3D-4EC3-84C9-2C88E874A5D1

Q37798817-2110505C-9D9C-4DF4-A0C7-85D9A4F68CB4

Q37798817-2D76135B-540B-4147-9663-CF60F0BCDF39

P304

Q37798817-CE2B529A-D566-47BE-86A6-466735ED9E75

P31

Q37798817-1EFB7A9B-5AAE-463A-9B47-D70C3478E112

P356

Q37798817-BCB6F13B-A29A-4340-B0DC-3D41FA19C63A

P433

Q37798817-75C29379-8D25-47DE-8703-F08E517EECA4

P478

Q37798817-5E932AA8-1DB0-45B2-A5E3-FFF450BE1382

P577

Q37798817-74E18F2A-A225-4954-BDDD-93CA8A888BAE

P698

Q37798817-331F2CD4-E7F7-4C91-B8BC-7E57F4360849

P356

P1433

Expert Review of Gastroenterology & Hepatology

P1476

Developing better treatments in hepatocellular carcinoma.

@en

P2093

Austin Duffy

http://www.w3.org/2001/XMLSchema#string

Tim Greten

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Modes of resistance to anti-angiogenic therapy

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Sorafenib in advanced hepatocellular carcinoma

Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Management of hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

P304

551-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EGH.10.58

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20932140

http://www.w3.org/2001/XMLSchema#string